Goldman Sachs Group Inc Tenaya Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 280,223 shares of TNYA stock, worth $526,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
280,223
Previous 211,171
32.7%
Holding current value
$526,819
Previous $120,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding TNYA
# of Institutions
95Shares Held
37MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$17.7 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$8.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.66 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$4.25 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$3.47 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $77.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...